189 related articles for article (PubMed ID: 19696983)
1. [Surgical treatment of gastrointestinal stromal tumors].
Bareck E; Längle F; Zacherl J
Wien Med Wochenschr; 2009; 159(15-16):393-8. PubMed ID: 19696983
[TBL] [Abstract][Full Text] [Related]
2. [Indications for pre- and postoperative treatment with imatinib for gastrointestinal stromal tumors].
Heger U; Weitz J; Lordick F
Chirurg; 2008 Jul; 79(7):630-7. PubMed ID: 18548219
[TBL] [Abstract][Full Text] [Related]
3. Critical update and emerging trends in imatinib treatment for gastrointestinal stromal tumor.
De Giorgi U; Pupi A; Turrisi G; Montenora I; Morini S; Fayyaz M; De Simone M; Fiorentini G
Rev Recent Clin Trials; 2007 Jan; 2(1):43-8. PubMed ID: 18473987
[TBL] [Abstract][Full Text] [Related]
4. [Gastrointestinal stromal tumors: recommendations for diagnosis, treatment and aftercare in Austria].
Ploner F; Zacherl J; Wrba F; Längle F; Bareck E; Eisterer W; Kühr T; Schima W; Häfner M; Brodowicz T;
Wien Med Wochenschr; 2009; 159(15-16):370-82. PubMed ID: 19696980
[TBL] [Abstract][Full Text] [Related]
5. A rare case of rapid growth of exophytic gastrointestinal stromal tumor of the stomach.
Ding G; Yang J; Cheng S; Kai L; Nan L; Zhang S; Cong W; Wu M
Dig Dis Sci; 2005 May; 50(5):820-3. PubMed ID: 15906751
[No Abstract] [Full Text] [Related]
6. Six months neoadjuvant imatinib improves resectability potential of gastric stromal tumors in Egyptian patients.
Saied GM; Kensarah AM
Int J Surg; 2010; 8(2):105-8. PubMed ID: 19944196
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
Eisenberg BL; Harris J; Blanke CD; Demetri GD; Heinrich MC; Watson JC; Hoffman JP; Okuno S; Kane JM; von Mehren M
J Surg Oncol; 2009 Jan; 99(1):42-7. PubMed ID: 18942073
[TBL] [Abstract][Full Text] [Related]
8. Surgical outcomes of patients with gastrointestinal stromal tumors in the era of targeted drug therapy.
Nikfarjam M; Kimchi E; Shereef S; Gusani NJ; Jiang Y; Liang J; Sehmbey M; Staveley-O'Carroll KF
J Gastrointest Surg; 2008 Nov; 12(11):2023-31. PubMed ID: 18546049
[TBL] [Abstract][Full Text] [Related]
9. That's the "GIST" of it: use of adjuvant imatinib after resection of a primary GI stromal tumor.
Tap WD; Schwartz GK
J Clin Oncol; 2014 May; 32(15):1543-6. PubMed ID: 24638004
[No Abstract] [Full Text] [Related]
10. Laparoscopic resection of a gastrointestinal stromal tumor of the rectum after treatment with imatinib mesylate: report of a case.
Nakamura T; Mitomi H; Onozato W; Sato T; Ikeda A; Naito M; Ogura N; Kamata H; Ooki A; Watanabe M
Surg Today; 2012 Nov; 42(11):1096-9. PubMed ID: 22294424
[TBL] [Abstract][Full Text] [Related]
11. Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients?
Mussi C; Ronellenfitsch U; Jakob J; Tamborini E; Reichardt P; Casali PG; Fiore M; Hohenberger P; Gronchi A
Ann Oncol; 2010 Feb; 21(2):403-408. PubMed ID: 19628568
[TBL] [Abstract][Full Text] [Related]
12. Combining imatinib with surgery in gastrointestinal stromal tumors: rationale and ongoing trials.
Eisenberg BL
Clin Colorectal Cancer; 2006 Nov; 6 Suppl 1():S24-9. PubMed ID: 17101065
[TBL] [Abstract][Full Text] [Related]
13. [Aspects of surgical treatment for gastro-intestinal stromal tumors].
Hohenberger P
Radiologe; 2009 Dec; 49(12):1122-7. PubMed ID: 19937425
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
Tielen R; Verhoef C; van Coevorden F; Gelderblom H; Sleijfer S; Hartgrink HH; Bonenkamp JJ; van der Graaf WT; de Wilt JH
Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary treatment of gastrointestinal stromal tumors.
Kingham TP; DeMatteo RP
Surg Clin North Am; 2009 Feb; 89(1):217-33, x. PubMed ID: 19186237
[TBL] [Abstract][Full Text] [Related]
16. Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China.
Du CY; Zhou Y; Song C; Wang YP; Jie ZG; He YL; Liang XB; Cao H; Yan ZS; Shi YQ
Eur J Cancer; 2014 Jul; 50(10):1772-1778. PubMed ID: 24768330
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
Joensuu H; Eriksson M; Hall KS; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Ballman KV; Leinonen M; DeMatteo RP; Reichardt P
Cancer; 2014 Aug; 120(15):2325-33. PubMed ID: 24737415
[TBL] [Abstract][Full Text] [Related]
18. Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors.
Blay JY; Pérol D; Le Cesne A
Ann Oncol; 2012 Jul; 23(7):1659-65. PubMed ID: 22357253
[TBL] [Abstract][Full Text] [Related]
19. Combined Therapy of Gastrointestinal Stromal Tumors.
Rutkowski P; Hompes D
Surg Oncol Clin N Am; 2016 Oct; 25(4):735-59. PubMed ID: 27591496
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal stromal tumors: current management.
Pisters PW; Patel SR
J Surg Oncol; 2010 Oct; 102(5):530-8. PubMed ID: 20063363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]